131 related articles for article (PubMed ID: 8909100)
1. Investigations of directly labeling antibodies with rhenium-188.
Winnard P; Virzi E; Fogarasi M; Rusckowski M; Hnatowich DJ
Q J Nucl Med; 1996 Jun; 40(2):151-60. PubMed ID: 8909100
[TBL] [Abstract][Full Text] [Related]
2. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
[TBL] [Abstract][Full Text] [Related]
3. Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies.
Griffiths GL; Goldenberg DM; Knapp FF; Callahan AP; Chang CH; Hansen HJ
Cancer Res; 1991 Sep; 51(17):4594-602. PubMed ID: 1873804
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site.
Ogawa K; Kawashima H; Kinuya S; Shiba K; Onoguchi M; Kimura H; Hashimoto K; Odani A; Saji H
Ann Nucl Med; 2009 Dec; 23(10):843-8. PubMed ID: 19921351
[TBL] [Abstract][Full Text] [Related]
6. Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?
Hnatowich DJ; Virzi F; Fogarasi M; Rusckowski M; Winnard P
Nucl Med Biol; 1994 Nov; 21(8):1035-44. PubMed ID: 9234361
[TBL] [Abstract][Full Text] [Related]
7. Recombinant metallothionein-conjugated streptavidin labeled with 188Re and 99mTc.
Virzi F; Winnard P; Fogarasi M; Sano T; Smith CL; Cantor CR; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 1995; 6(1):139-44. PubMed ID: 7711101
[TBL] [Abstract][Full Text] [Related]
8. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
[TBL] [Abstract][Full Text] [Related]
9. [Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma].
Zhao ZG; Ran YL; Zheng R; Kong J; Chen SZ; Yu L; Yang ZH
Ai Zheng; 2002 May; 21(5):460-3. PubMed ID: 12452032
[TBL] [Abstract][Full Text] [Related]
10. Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m.
Childs RL; Hnatowich DJ
J Nucl Med; 1985 Mar; 26(3):293-9. PubMed ID: 3882905
[TBL] [Abstract][Full Text] [Related]
11. 188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases.
El-Mabhouh A; Mercer JR
Appl Radiat Isot; 2005 Apr; 62(4):541-9. PubMed ID: 15701408
[TBL] [Abstract][Full Text] [Related]
12. Investigations of ascorbate for direct labeling of antibodies with technetium-99m.
Hnatowich DJ; Virzi F; Winnard P; Fogarasi M; Rusckowski M
J Nucl Med; 1994 Jan; 35(1):127-34. PubMed ID: 8271033
[TBL] [Abstract][Full Text] [Related]
13. Studies on the uptake mechanisms of 99mTc-labeled antibodies by liver tissue.
Xue LY; Noujaim AA; Sykes TR; Peng Z
Q J Nucl Med; 1996 Jun; 40(2):176-81. PubMed ID: 8909103
[TBL] [Abstract][Full Text] [Related]
14. Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice.
Hosono MN; Hosono M; Zamora PO; Guhlke S; Haberberger T; Bender H; Knapp FF; Biersack HJ
Ann Nucl Med; 1998 Apr; 12(2):83-8. PubMed ID: 9637278
[TBL] [Abstract][Full Text] [Related]
15. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
[TBL] [Abstract][Full Text] [Related]
16. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
[TBL] [Abstract][Full Text] [Related]
17. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
[TBL] [Abstract][Full Text] [Related]
18. Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones.
Uehara T; Jin ZL; Ogawa K; Akizawa H; Hashimoto K; Nakayama M; Arano Y
Nucl Med Biol; 2007 Jan; 34(1):79-87. PubMed ID: 17210464
[TBL] [Abstract][Full Text] [Related]
19. Derivatives of 1,3,5-triamino-1,3,5-trideoxy-cis-inositol as versatile pentadentate ligands for protein labeling with Re-186/188. prelabeling, biodistribution, and X-ray structural studies.
Kramer A; Alberto R; Egli A; Novak-Hofer I; Hegetschweiler K; Abram U; Bernhardt PV; Schubiger PA
Bioconjug Chem; 1998; 9(6):691-702. PubMed ID: 9815162
[TBL] [Abstract][Full Text] [Related]
20. A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine.
Wunderlich G; Drews A; Kotzerke J
Appl Radiat Isot; 2005 Jun; 62(6):915-8. PubMed ID: 15799869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]